Achieving Process Intensification by Scheduling and Debottlenecking Biotech Processes - An approach to reduce batch time, increase productivity, and decrease costs. - BioPharm International

ADVERTISEMENT

Achieving Process Intensification by Scheduling and Debottlenecking Biotech Processes
An approach to reduce batch time, increase productivity, and decrease costs.


BioPharm International
Volume 24, Issue 2, pp. 44-53

CONCLUSIONS

The methods in this article illustrate how process scheduling and debottlenecking can result in process intensification, thus reducing batch time, increasing plant productivity and, ultimately, decreasing the cost of manufacturing. The first case study focused on the procedure for scheduling a biotech process, debottlenecking, economical and optimal scale-up, developing a buffer preparation model, and optimizing the number of buffer and media preparation and hold-up tanks. The second case study demonstrated the development of a model for buffer preparation and the optimization of the total number of tanks required for a multiproduct biotech facility.

Anurag S. Rathore is a biotech CMC consultant and a faculty member, and Tarun Sengar is a student in the department of chemical engineering, both at the Indian Institute of Technology, Delhi, India, +91 9650770650,
. Rathore is also a member of the BioPharm International editorial advisory board.

REFERENCES

1. Gosling I. Process simulation and modeling strategies for the biotechnology industry. Optimizing productivity in multiproduct batch facilities. Gen Eng News. Sep 2003. Available from: http://www.chemsim.com/.

2. Toumi A, et al. Design and optimization of a large scale biopharmaceutical facility using optimization and scheduling tools. Pharm Eng. 2010;30(2):1–9.

3. Petridis D, Koulouris A, Siletti C. Throughput analysis and debottlenecking of biomanufacturing facilities. Biopharm Int. 2002 Aug suppl;28–64.

4. Yuan JQ, et al. Profit optimization for mycleia fed-batch cultivation. J Biotech. 1997;54:175–93.

5. Papavasileiou V, Koulouris A, Siletti C, Petrides D, Trans I. Optimize manufacturing of Pharmaceutical products with process simulation and production scheduling tools. ChemE Part A. 2007;85(A7):1086–97.

6. Petrides D, Siletti C. The role of process simulation and scheduling tools in the development and product commercialization. Pharm Eng. 2002;22(1).


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

First Biosimilar Application Kicks Off Legal Battle
October 31, 2014
FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Author Guidelines
Source: BioPharm International,
Click here